Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Batu Biologics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Batu Biologics

Batu Biologics

Batu Biologics: A preclinical biopharma firm developing allogeneic cell therapies for immune modulation.

HQ
San Diego, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer treatment, Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therapies for immune modulation. The company's core vision is to create or break immune tolerance to treat various diseases effectively. Batu Biologics is currently advancing two flagship products, Immstem and Vallovax, both in the preclinical stages of drug development. The company has also filed two provisional patents in the field of cancer immunotherapy, aiming to expand its intellectual property significantly.

Notable figures associated with Batu Biologics include experts in oncology and immunotherapy, although specific names are not provided. The company has garnered attention for its innovative approach to cancer treatment, particularly through its development of allogeneic cell therapies. Key achievements include the progression of its flagship products and the filing of provisional patents, which underscore its potential impact on the biopharmaceutical industry. Batu Biologics continues to make strides in preclinical research, positioning itself as a promising player in the field of cancer immunotherapy.

Batu Biologics - Similar Companies

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

ImmuneBridge logo

ImmuneBridge

immunebridge.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Platelet BioGenesis logo

Platelet BioGenesis

INmune Bio logo

INmune Bio

inmunebio.com

Bullet Biotechnology logo

Bullet Biotechnology

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Be Biopharma logo

Be Biopharma

ImmunityBio logo

ImmunityBio

immunitybio.com

Abintus Bio logo

Abintus Bio

abintusbio.com

Avenge Bio logo

Avenge Bio

avengebio.com

Alloplex Biotherapeutics logo

Alloplex Biotherapeutics

Cellular Approaches logo

Cellular Approaches

Catamaran Bio logo

Catamaran Bio

catamaranbio.com

Bicara Therapeutics logo

Bicara Therapeutics

Batu Biologics - Quick Facts

Who are Batu Biologics' competitors?

Companies similar to Batu Biologics include Cell BioEngines, ImmuneBridge, Immpact Bio and Platelet BioGenesis.

When was Batu Biologics founded?

Batu Biologics was founded in 2013.

Where is Batu Biologics' headquarters located?

Batu Biologics' headquarters is located in San Diego, CA, US.

When was Batu Biologics' last funding round?

Batu Biologics' most recent funding round was for $1.3M (USD) in December 2017.

How much has Batu Biologics raised to-date?

As of Dec 25, 2017, Batu Biologics has raised a total of $2.8M (USD).

How many employees does Batu Biologics have?

Batu Biologics has 6 employees as of Feb 5, 2024.

Batu Biologics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Customer
  • Enterprise
  • Government
Main Product
  • Cell Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified